Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?
Friedman JM, Bombard Y, Carleton B, Issa AM, Knoppers B, Plon SE, Rahimzadeh V, Relling MV, Williams MS, van Karnebeek C, Vears D, Cornel MC; Global Alliance for Genomics and Health Regulatory and Ethics Workstream.
Friedman JM, et al. Among authors: issa am.
Genet Med. 2024 Feb;26(2):101033. doi: 10.1016/j.gim.2023.101033. Epub 2023 Nov 23.
Genet Med. 2024.
PMID: 38007624
Free article.